Zhejiang Jingxin Pharmaceutical Co Ltd Class A 002020
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥11.34
- Day Range
- ¥11.47–11.98
- 52-Week Range
- ¥8.28–15.25
- Bid/Ask
- ¥11.74 / ¥11.75
- Market Cap
- ¥10.12 Bil
- Volume/Avg
- 19.7 Mil / 10.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 17.19
- Price/Sales
- 2.40
- Dividend Yield (Trailing)
- 2.55%
- Dividend Yield (Forward)
- 2.55%
- Total Yield
- 2.55%
Company Profile
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,909
- Website
- http://www.jingxinpharm.com
Comparables
Valuation
|
Metric
|
002020
|
600216
|
000739
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.19 | 64.26 | 18.32 |
Price/Book Value | 1.79 | 1.56 | 2.91 |
Price/Sales | 2.40 | 1.85 | 1.54 |
Price/Cash Flow | 10.07 | 14.96 | 9.69 |
Price/Earnings
002020
600216
000739
Financial Strength
|
Metric
|
002020
|
600216
|
000739
|
|---|---|---|---|
Quick Ratio | 0.85 | 1.68 | 0.97 |
Current Ratio | 1.24 | 2.66 | 1.30 |
Interest Coverage | 85.45 | 15.43 | 35.39 |
Quick Ratio
002020
600216
000739
Profitability
|
Metric
|
002020
|
600216
|
000739
|
|---|---|---|---|
Return on Assets (Normalized) | 7.21% | 1.81% | 7.96% |
Return on Equity (Normalized) | 10.57% | 2.37% | 16.93% |
Return on Invested Capital (Normalized) | 8.90% | 2.20% | 13.55% |
Return on Assets
002020
600216
000739
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Nrpxbtftcp | Shcp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Gcdbhtrc | Xlncjrb | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Nrqhtkyrj | Nzg | $48.4 Bil | |||
| Viatris Inc
VTRS
| Wsdxfsqqz | Vhc | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Lpnwjtnt | Yzxc | $13.5 Bil | |||
| Catalent Inc
CTLT
| Ldqjyhx | Ckjmkt | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tfkjqmlhr | Ckzxzy | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Vxvkrgb | Vnjd | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Smhypnkfsj | Fwdxl | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Wrfcjbj | Ysf | $2.3 Bil |
United States